There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.
Interview with Joachim Haupt and Florian Kaiser, PharmAI
The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.
Management pays a lot of attention to new ideas and cutting-edge technologies, but most of their resources are consumed by mature legacy technologies that are often not actively and rigorously managed. A visual matrix can help teams understand which technologies offer the greatest long-term potential for businesses.
Industry 5.0 makes it possible to harness the skills and creativity of people to improve the safety and productivity of chemical and pharmaceutical production processes.
For many years, fine and specialty chemicals markets were on a robust growth path.
Oxiteno Indústria e Comércio, a Brazilian manufacturer of surfactants and specialty chemicals, and Harke Pharma, part of the international Harke Group with headquarters in Muelheim an der Ruhr, Germany, have agreed on a strategic partnership for the marketing of the Oxipurity 4000 line in Eastern Europe, Nordics, Turkey, the Netherlands, Italy and Slovenia.
In many industrial applications the wet sulfuric acid process is the most important technology for recovery of sulfuric acid and energy from sulfur bearing compounds.
At an online roundtable event hosted by CHEManager, a group of industry experts discussed the reasons why microreaction technology (MRT) has not achieved the status for instance in fine chemicals and active ingredients production that one might expect as well as various business and production aspects of the technology.
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment a few years ago and meanwhile has passed certain milestones on its way to become a preferred oligonucleotide manufacturing partner for pharmaceutical companies.
To prove to its customers that the plastic they use contains certain amounts of chemical recycled content, Mitsubishi Chemical Europe piloted the GreenToken solution by SAP in their methyl methacrylate (MMA) supply chain.
Chemical distributor Oqema Poland, part of Oqema Group, partners with global flavor and ingredient supplier Flavorchem Europe, adding a wide range of flavors, extracts, ingredients and color solutions to its existing portfolio.
Learn about the merits of cryo condensation and its unique sustainability for the pharmaceutical industry.
ACG, an integrated solutions provider for pharmaceutical companies, has introduced the Smart Connected Product – a new, innovative, IIoT solution, that connects production machines at any facility and visualizes relevant information on a single platform. This data can be viewed over the web on any device with a secure connection and is accessible only to authorized users.
Biesterfeld Spezialchemie has been granted the distribution rights for Solvay's advanced composite materials such as prepregs, adhesive films, adhesives and primers that are predominantly used in aviation, automotive and other industrial applications.
Global specialty chemicals distributor Safic-Alcan and Imerys, a supplier of mineral-based specialty solutions, have announced the extension of their existing partnership to performance products applications.
Storage conditions play a vital role in the entire supply chain of pharmaceutical products and must comply with strict regulations. From manufacturers to patients, storage conditions are essential for the quality, safety, and efficacy of medications.
The positive impacts of Predictive Maintenance are broad and should be considered holistically. No one ever said that nurturing a perfect rose garden was simple, but the results can be dramatic.
Interview with Oliver Reimann and Andreas Regnery, Belyntic
Biovox was founded in 2020 to enable more sustainability through renewable bioplastics even in difficult applications such as consumables in healthcare or machine parts.
Munio is developing streamlined and efficient learning and access systems that enable business park operators to offer flexibility to their tenants while maintaining control.
Yncoris has started marketing “The New Knapsite”, one of the largest sites available in Europe for the development of sophisticated process industries and sustainable chemistry of the future. The site offers optimal logistical connections as well as excellent links to the existing Knapsack Chemical Park and the infrastructure it provides.
Chemical MNCs show strong verbal commitment to China, but the real situation is somewhat underwhelming.
Antwerp is the home port of the largest integrated chemical cluster in Europe. It is the place for entering into partnerships throughout the chain and even across sectors.
If you follow the daily news on climate protection and the promotion of hydrogen technologies, you sometimes get a sense of déjà vu: Didn't this already exist 20 years ago? What was implemented at that time? What sustainable hydrogen-based technologies can we expect today?
Interview with Jere Koskinen and Ali Harlin, Mega Cellulose.
Effective July 1, 2021, Evonik has carved out its Baby Care business, i.e., the production and distribution of superabsorbents and acrylic acid, and transferred it to independent companies in Germany and in the USA.
By fully realizing the potential of data-driven analysis and machine learning, chemical producers can maximize plant uptime and optimize process efficiency.
The poor healing ability of tendons as well as the limitations of currently used therapies have motivated tissue engineering (TE) strategies to develop living tendon substitutes.
When advancing from research to production, your supplier’s experience, portfolio and customization capabilities are key to your success.
The increasing complexity of drug products brings pharmaceutical companies significant manufacturing challenges arising from the pandemic. This includes disrupting supply chains and requiring changes to business and operational processes to accommodate social distancing, remote work and quarantining. The industry has been in constant transition from producing block-buster medicines towards personalized medicine to break-through vaccines, which for production teams, means there will be increasing variations in the production processes.
